menu
    • menu
    [{"orgOrder":0,"company":"Sanofi","sponsor":"Corona Remedies","pharmaFlowCategory":"D","therapeuticArea":"Musculoskeletal","country":"FRANCE","productType":"Miscellaneous","year":"2023","type":"Acquisition","leadProduct":"Thiocolchicoside","moa":"GABA(A) receptor alpha-1 (GABRA1)","graph1":"Musculoskeletal","graph2":"Approved FDF","graph3":"Sanofi","amount2":0.029999999999999999,"highestDevelopmentShortName":"Approved FDF","therapeuticAreaShortName":"Musculoskeletal","amount2New":0.029999999999999999,"dosageForm":"Capsule","sponsorNew":"Sanofi \/ Corona Remedies","highestDevelopmentStatusID":"15","companyTruncated":"Sanofi \/ Corona Remedies"},{"orgOrder":0,"company":"Cosmos Health","sponsor":"Libytec Pharmaceutical","pharmaFlowCategory":"D","therapeuticArea":"Musculoskeletal","country":"U.S.A","productType":"Miscellaneous","year":"2026","type":"Agreement","leadProduct":"Thiocolchicoside","moa":"GABAA receptor alpha-1","graph1":"Musculoskeletal","graph2":"Approved FDF","graph3":"Cosmos Health","amount2":0,"highestDevelopmentShortName":"Approved FDF","therapeuticAreaShortName":"Musculoskeletal","amount2New":0,"dosageForm":"Tablet, Film Coated","sponsorNew":"Cosmos Health \/ Libytec Pharmaceutical","highestDevelopmentStatusID":"15","companyTruncated":"Cosmos Health \/ Libytec Pharmaceutical"}]

    Find Clinical Drug Pipeline Developments & Deals for Miorel

    Menu

    Miorel

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            Sanofi

                            France
                            BIO Partnering at JPM
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

                            Lead Product(s) : Thiocolchicoside

                            Therapeutic Area : Musculoskeletal

                            Study Phase : Approved FDF

                            Sponsor : Corona Remedies

                            Deal Size : $28.5 million

                            Deal Type : Acquisition

                            DEALS_DEV arrow-down

                            CORONA Remedies Buys India's Ortho Brand Myoril

                            Details : Through the acquisition, Corona Remedies gains right for the leading muscle relaxant brand Myoril (thiocolchicoside) and its extensions such as Myoril Plus (ketoprofen and thiocolchicoside) to treat muscular pain.

                            Product Name : Myoril

                            Product Type : Miscellaneous

                            Upfront Cash : Undisclosed

                            June 28, 2023

                            Lead Product(s) : Thiocolchicoside

                            Therapeutic Area : Musculoskeletal

                            Highest Development Status : Approved FDF

                            Sponsor : Corona Remedies

                            Deal Size : $28.5 million

                            Deal Type : Acquisition

                            Sanofi Company Banner

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            02

                            Cosmos Health

                            U.S.A arrow
                            BIO Partnering at JPM
                            Not Confirmed

                            Cosmos Health

                            U.S.A arrow
                            BIO Partnering at JPM
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Thiocolchicoside,Paracetamol

                            Therapeutic Area : Musculoskeletal

                            Study Phase : Approved FDF

                            Sponsor : Libytec Pharmaceutical

                            Deal Size : Undisclosed

                            Deal Type : Agreement

                            DEALS_DEV arrow-down

                            Cosmos Health, Libytec Partner for PathMuscle Medicine Manufacturing, 5-Year Volumes >1.2M

                            Details : The agreement will support the clinical development of Thiocolchicoside for painful muscle spasms by targeting the GABAA receptor alpha-1.

                            Product Name : PathMuscle

                            Product Type : Miscellaneous

                            Upfront Cash : Undisclosed

                            January 05, 2026

                            Lead Product(s) : Thiocolchicoside,Paracetamol

                            Therapeutic Area : Musculoskeletal

                            Highest Development Status : Approved FDF

                            Sponsor : Libytec Pharmaceutical

                            Deal Size : Undisclosed

                            Deal Type : Agreement

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            • Privacy policy
                            • Terms and conditions
                            • Disclaimers
                            • LinkedIn
                            • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.